IL113074A - Hypocholesterolemic antiatherosclerotic and hypotriglyceridemic pharmaceutical compositions comprising derivatives of mercaptoacetamido-oxopyrrolo (and pyrido) benzazepinecarboxylic acids - Google Patents

Hypocholesterolemic antiatherosclerotic and hypotriglyceridemic pharmaceutical compositions comprising derivatives of mercaptoacetamido-oxopyrrolo (and pyrido) benzazepinecarboxylic acids

Info

Publication number
IL113074A
IL113074A IL11307495A IL11307495A IL113074A IL 113074 A IL113074 A IL 113074A IL 11307495 A IL11307495 A IL 11307495A IL 11307495 A IL11307495 A IL 11307495A IL 113074 A IL113074 A IL 113074A
Authority
IL
Israel
Prior art keywords
derivatives
benzazepinecarboxylic
mercaptoacetamido
hypotriglyceridemic
oxopyrrolo
Prior art date
Application number
IL11307495A
Other languages
English (en)
Other versions
IL113074A0 (en
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of IL113074A0 publication Critical patent/IL113074A0/xx
Publication of IL113074A publication Critical patent/IL113074A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
  • Artificial Filaments (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
IL11307495A 1994-03-24 1995-03-22 Hypocholesterolemic antiatherosclerotic and hypotriglyceridemic pharmaceutical compositions comprising derivatives of mercaptoacetamido-oxopyrrolo (and pyrido) benzazepinecarboxylic acids IL113074A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/217,781 US5484783A (en) 1994-03-24 1994-03-24 Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide and benzazapine derivatives

Publications (2)

Publication Number Publication Date
IL113074A0 IL113074A0 (en) 1995-06-29
IL113074A true IL113074A (en) 2000-07-26

Family

ID=22812484

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11307495A IL113074A (en) 1994-03-24 1995-03-22 Hypocholesterolemic antiatherosclerotic and hypotriglyceridemic pharmaceutical compositions comprising derivatives of mercaptoacetamido-oxopyrrolo (and pyrido) benzazepinecarboxylic acids

Country Status (20)

Country Link
US (1) US5484783A (de)
EP (1) EP0751775B1 (de)
JP (1) JPH09510220A (de)
KR (1) KR970701550A (de)
CN (1) CN1144483A (de)
AT (1) ATE217527T1 (de)
AU (1) AU705029B2 (de)
CA (1) CA2184693C (de)
DE (1) DE69526731T2 (de)
DK (1) DK0751775T3 (de)
ES (1) ES2173180T3 (de)
FI (1) FI118414B (de)
HU (1) HU226643B1 (de)
IL (1) IL113074A (de)
NO (1) NO313176B1 (de)
NZ (1) NZ282949A (de)
PT (1) PT751775E (de)
TW (1) TW323954B (de)
WO (1) WO1995025548A2 (de)
ZA (1) ZA952285B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6635632B1 (en) 1996-12-23 2003-10-21 Athena Neurosciences, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US5834353A (en) * 1997-10-20 1998-11-10 Texas Instruments-Acer Incorporated Method of making deep sub-micron meter MOSFET with a high permitivity gate dielectric
US6378430B1 (en) 1999-10-15 2002-04-30 King Press Corporation Cylinder with plate gripping device
DE10229180A1 (de) * 2002-06-28 2004-01-29 Aventis Pharma Deutschland Gmbh Verwendung von Vasopeptidase-Inhibitoren bei der Behandlung von metabolischen Erkrankungen, Nephropathie und mit AGE assoziierten Erkrankungen
ES2332051T3 (es) * 2003-10-08 2010-01-25 Eli Lilly And Company Compuestos y procedimientos para tratar dislipidemia.

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3334095A (en) * 1965-02-16 1967-08-01 Sandoz Ag Novel pyrrolo-oxazines and pyrrolo-oxazoles
US3334091A (en) * 1965-03-25 1967-08-01 Sandoz Ag Sedatives
GB1525845A (en) * 1976-07-30 1978-09-20 Ucb Sa 1,2,4,5-tetrahydro-3h-2-benzazepin-3-ones
IE50839B1 (en) * 1980-02-26 1986-07-23 Wyeth John & Brother Ltd Novel processes for preparing proline derivatives and analogous compounds
EP0042100A1 (de) * 1980-06-13 1981-12-23 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Pyrazolopyridazin-Derivate, Zwischenprodukte und Verfahren zu deren Herstellung, sowie diese enthaltende Arzneimittel
US4320057A (en) * 1980-06-23 1982-03-16 American Home Products Corporation Aryl--pyrrolo--thiazepin--diones and aryl--piperidino--thiazepin--diones
US4415496A (en) * 1981-03-23 1983-11-15 Merck & Co., Inc. Bicyclic lactams
GB2128984B (en) * 1982-05-12 1985-05-22 Hoffmann La Roche Diaza-bicyclic compounds
ZA833214B (en) * 1982-05-12 1983-12-28 Hoffmann La Roche Bicyclic compounds
US4552889A (en) * 1983-06-09 1985-11-12 Eli Lilly And Company 3-Mercaptomethyl-2-oxo-1-pyrrolidine acetic acids and use for hypertension
US4692438A (en) * 1984-08-24 1987-09-08 Hoffmann-La Roche Inc. Pyridazo-diazepines, diazocines, and -triazepines having anti-hypertensive activity
US4584294A (en) * 1984-11-07 1986-04-22 Merck & Co., Inc. Fused tricyclic lactams as angiotensin converting enzyme inhibitors and as antihypertensive agents
ES8801833A1 (es) * 1985-04-30 1988-02-16 Lilly Co Eli Un procedimiento para la preparacion de un compuesto.
ZA874107B (de) * 1986-06-13 1987-12-09
US4973585A (en) * 1986-06-13 1990-11-27 Merrell Dow Pharmaceuticals Tricyclic lactams active as antihypertensive agents
ZA874106B (en) * 1986-06-13 1987-12-08 Merrell Dow Pharmaceuticals Inc. Novel antihypertensive agent
GB8629875D0 (en) * 1986-12-15 1987-01-28 Hoffmann La Roche Pyridazodiazepine derivatives
US4824832A (en) * 1987-12-30 1989-04-25 Merrell Dow Pharmaceuticals Inc. Sulfhydryl containing tricyclic lactams and their pharmacological methods of use
US5061694A (en) * 1989-10-23 1991-10-29 E. R. Squibb & Sons, Inc. Method for stabilizing or causing regression of atherosclerosis in coronary arteries employing an ace inhibitor
GB8926512D0 (en) * 1989-11-23 1990-01-10 Pfizer Ltd Therapeutic agents
AU7168091A (en) * 1989-12-22 1991-07-24 Schering Corporation Mercaptocycloacyl aminoacid endopeptidase inhibitors
CA2053340C (en) * 1990-10-18 2002-04-02 Timothy P. Burkholder Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
US5208230A (en) * 1990-12-21 1993-05-04 Merrell Dow Pharmaceuticals Amino and nitro containing tricyclic compounds useful as inhibitors of ACE
DK0492369T3 (da) * 1990-12-21 1997-10-13 Merrell Pharma Inc Hidtil ukendte tricycliske amino- og nitro-forbindelser med ACE-hæmmende virkning
FR2679564A1 (fr) * 1991-07-23 1993-01-29 Inst Nat Sante Rech Med Nouveaux acylmercaptoalcanoldipeptides, leur preparation et les compositions qui les contiennent.
AU2650692A (en) * 1991-09-16 1993-04-27 Schering Corporation Pharmaceutical compositions comprising natriuretic peptides or neutral endopeptidase inhibitors for treating or preventing myointimal proliferation
RU2124503C1 (ru) * 1992-05-18 1999-01-10 И.Р.Сквибб энд Санз, Инк. Гетероциклические азотсодержащие производные карбоновой кислоты, способ их получения и фармацевтическая композиция
US5238932A (en) * 1992-05-20 1993-08-24 Merrell Dow Pharmaceuticals Inc. Mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase

Also Published As

Publication number Publication date
AU2091495A (en) 1995-10-09
HUT74886A (en) 1997-02-28
EP0751775A1 (de) 1997-01-08
PT751775E (pt) 2002-10-31
FI963785L (fi) 1996-09-23
NO963989L (no) 1996-11-22
HU9602603D0 (en) 1996-11-28
ES2173180T3 (es) 2002-10-16
AU705029B2 (en) 1999-05-13
ZA952285B (en) 1996-01-09
US5484783A (en) 1996-01-16
CN1144483A (zh) 1997-03-05
NO963989D0 (no) 1996-09-23
IL113074A0 (en) 1995-06-29
JPH09510220A (ja) 1997-10-14
NZ282949A (en) 1997-07-27
WO1995025548A2 (en) 1995-09-28
TW323954B (en) 1998-01-01
NO313176B1 (no) 2002-08-26
EP0751775B1 (de) 2002-05-15
HU226643B1 (en) 2009-05-28
WO1995025548A3 (en) 1995-11-09
CA2184693C (en) 2001-01-02
DK0751775T3 (da) 2002-08-26
DE69526731T2 (de) 2003-02-06
KR970701550A (ko) 1997-04-12
FI118414B (fi) 2007-11-15
DE69526731D1 (en) 2002-06-20
FI963785A0 (fi) 1996-09-23
CA2184693A1 (en) 1995-09-28
ATE217527T1 (de) 2002-06-15

Similar Documents

Publication Publication Date Title
HUP9904221A3 (en) Use of cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia for producing pharmaceutical compositions
DE69726577D1 (en) Kristallin form i von clarithromycin
AU7606296A (en) Method and apparatus for the application of textile treatment compositions to textile materials
MX9704030A (es) 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos.
AUPO727097A0 (en) Method of treatment of hepatoma and pharmaceutical compositions for use therein
HUP9901359A3 (en) Azetidinone derivatives for the treatment of atherosclerosis, process for their producing and pharmaceutical compositions containing them
EP0902789A4 (de)
PT758241E (pt) Utilizacao de certos derivados de acido metanobisfosfonico para impedir o desprendimento de proteses e a migracao de proteses
HUP9901153A3 (en) Azetidinone derivatives for the treatment of atherosclerosis, their production and pharmaceutical compositions containing them
AU4133997A (en) Pharmaceutical composition for the treatment of syndrome x of reaven
IL113074A (en) Hypocholesterolemic antiatherosclerotic and hypotriglyceridemic pharmaceutical compositions comprising derivatives of mercaptoacetamido-oxopyrrolo (and pyrido) benzazepinecarboxylic acids
AU5963396A (en) Cis-resorcylide, pharmaceutical composition containing it, use thereof in the treatment of thrombosis and related disorders
ZA952284B (en) Hypocholesterolemic antiatherosclerotic and hypotriglyceridemic aminoacetylmercapto derivatives
ZA966577B (en) Pharmaceutical composition.
CA2184692A1 (en) Hypocholesterolemic, Antiatherosclerotic and Hypotriglyceridemic Mercaptoacetylamide Disulfide Derivatives
AU2300895A (en) Pharmaceutical composition comprising hyaluronic acid for the clearing of arteriosclerosis
AU5602898A (en) Pharmaceutical compositions for mucolysis and treatment of inflammation
IL119403A0 (en) Pharmaceutical composition for the treatment of syndrome X of reaven
IL119250A0 (en) Pharmaceutical composition for the treatment of syndrome X of reaven
UA32580C2 (uk) Засіб для лікування паралітичної непрохідності кишечнику
AUPM333594A0 (en) Pharmaceutical composition for the treatment of skin conditions
IL118877A0 (en) Pharmaceutical compositions for treatment of inflammation
HK1005411A (en) Pharmaceutical preparations and medicaments for the prevention and treatment of endothelial dysfunction

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees